| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.093 | 0.1 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |